110 participants
Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-10-26
- Start Date:
- 2001-11-30
- Completion:
- 2008-03-31
Conditions
- Breast Cancer
Interventions
- DRUG